Xu Y - Search Results

1

Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression.

Cheng Y, Wang D, Jiang J, Huang W, Li D, Luo J, Gu W, Mo W, Wang C, Li Y, Gu S, Xu Y. Cheng Y, et al. Among authors: xu y. Prostate. 2020 May;80(8):640-652. doi: 10.1002/pros.23976. Epub 2020 Apr 13. Prostate. 2020. PMID: 32282098

2

[Cystic lymphangioma of the spermatic cord in old man: a case report and review of the literature].

Li DJ, Xu YT, Guo WH, Huang RQ, Gu W, Xu XW, Xie M, Jing YF. Li DJ, et al. Zhonghua Nan Ke Xue. 2007 Sep;13(9):815-7. Zhonghua Nan Ke Xue. 2007. PMID: 17929560 Review. Chinese.

3

[Long-term efficacy of tubularized peritoneal free grafts as ureteral mucosal substitutes in dogs].

Jing YF, Xia SJ, Li DJ, Guo WH, Xu YT. Jing YF, et al. Zhonghua Yi Xue Za Zhi. 2011 Feb 15;91(6):412-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418916 Chinese.

4

[Devine's technique with free skin grafting for concealed penis with prepuce deficit].

Xu XW, Xu YT, Shen ZJ, Li DJ, Gu W, Huang RQ. Xu XW, et al. Zhonghua Nan Ke Xue. 2011 Jul;17(7):625-7. Zhonghua Nan Ke Xue. 2011. PMID: 21823347 Chinese.

5

A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.

Wang D, Wan X, Zhang Y, Kong Z, Lu Y, Sun X, Huang Y, Ji C, Li D, Luo J, Gu W, Wang C, Li Y, Xu Y. Wang D, et al. Among authors: xu y. Prostate. 2019 Sep;79(12):1362-1377. doi: 10.1002/pros.23840. Epub 2019 Jul 3. Prostate. 2019. PMID: 31269242

6

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.

Luo J, Xie Y, Zheng Y, Wang C, Qi F, Hu J, Xu Y. Luo J, et al. Among authors: xu y. Cancer Med. 2020 Jun;9(12):4310-4323. doi: 10.1002/cam4.2983. Epub 2020 Apr 20. Cancer Med. 2020. PMID: 32311223 Free PMC article.

7

Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth.

Luo J, Wang D, Wan X, Xu Y, Lu Y, Kong Z, Li D, Gu W, Wang C, Li Y, Ji C, Gu S, Xu Y. Luo J, et al. Among authors: xu y. Onco Targets Ther. 2020 Sep 18;13:9257-9267. doi: 10.2147/OTT.S245861. eCollection 2020. Onco Targets Ther. 2020. PMID: 32982312 Free PMC article.

8

Comprehensive Characterization of Androgen-Responsive circRNAs in Prostate Cancer.

Kong Z, Lu Y, Wan X, Luo J, Li D, Huang Y, Wang C, Li Y, Xu Y. Kong Z, et al. Among authors: xu y. Life (Basel). 2021 Oct 15;11(10):1096. doi: 10.3390/life11101096. Life (Basel). 2021. PMID: 34685466 Free PMC article.

9

AC016745.3 Regulates the Transcription of AR Target Genes by Antagonizing NONO.

Lu Y, Wan X, Huang W, Zhang L, Luo J, Li D, Huang Y, Li Y, Xu Y. Lu Y, et al. Among authors: xu y. Life (Basel). 2021 Nov 9;11(11):1208. doi: 10.3390/life11111208. Life (Basel). 2021. PMID: 34833084 Free PMC article.

10

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.

Huang H, Liu A, Liang Y, Xin Y, Liu J, Hao Y, Huang D, Chen L, Li W, Jiang G, Huang Y, Xu Y, Zhang J, Ma T, Xu D, Gao Y. Huang H, et al. Among authors: xu d, xu y. BMC Med. 2023 Sep 19;21(1):357. doi: 10.1186/s12916-023-03065-5. BMC Med. 2023. PMID: 37726806 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,255 results

Search Page

Filters